Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
暂无分享,去创建一个
M. Mamdani | C. Bell | S. Peacock | M. Trudeau | M. Crump | M. Krahn | J. Hoch | C. Sawka | S. Gavura | Jin Luo | K. Bremner | D. Hodgson | T. Sullivan | S. Khor | J. Beca | Linda Lee